Skip to main content

Table 1 clinical and laboratory features of patients with myeloid malignancies

From: GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies

Parameter AML CML MDS
Age, median (range) (years)a 54(2-86) 52(11-75) 63(39-85)
Sex (male/female) 44/28 8/7 5/2
WBC (×109/l)a 7.5(0.3-203.6) 83.4(2.8-168.7) 3.6(1.6-12.2)
Haemoglobin (g/dl)a 71(24-123) 91(50-134) 64(46-91)
Platelet count (×109/l)a 40(3-447) 200(20-850) 50(10-926)
Cytogenetics    
   Good 22   3
   Intermediate 35   3
   Poor 8   1
CD34(+/-) 35/26   
GRAF levela 3.88(0.01-169.75)b 23.51(0.01-157.42)c 10.20(0.25-45.90)b
  1. WBC, white blood cells; aMedian (range); bP < 0.001, compared with control; cP = 0.030, compared with control;